This issue addresses the needs of expanding companies in the bioscience and logistics industries. Our experts offer a wide variety of options based on their experience in these markets. In addition, our “Special Report” focuses on foreign-trade zones and the many benefits offered to pharmaceutical and 3PL providers. Our “Industry Outlooks” present interesting overviews of the bioscience and 3PL markets as they continue to grow. With this issue we are also launching the FTZ portal on our website. This comprehensive database is complete with contact information, subzones, ports of entry and additional information your company needs when looking to move into a foreign-trade zone.
For the past three decades, U.S. tariff rates have fallen significantly, with many new products eligible for duty-free importation into the United States. Yet, over the same timeframe, the use of the U.S. Foreign-Trade Zones program, which is predicated on the ability to reduce tariff costs, has risen. more....